After Hours Report

The S&P 500 (+0.4%), Nasdaq Composite (+0.6%), and Russell 2000 (+0.1%) closed with gains. The day started out slow, but buying picked up steam after Treasury yields moved lower. The 10-yr yield approached 4.50% overnight, but settled one basis point lower than Friday at 4.41%.

The upside bias was also fueled by buy-the-dip interest following last week's consolidation, which saw the major indices give back some of their post-election gains. Strength in mega-cap stocks and semiconductor-related names contributed to overall index gains. However, NVIDIA (NVDA 140.15, -1.83, -1.3%) was among the outliers, trading lower after reports from The Information suggested customers are concerned about overheating issues with its AI chips. The company is set to report earnings after Wednesday’s close.

Meanwhile, Tesla (TSLA 338.74, +18.02, +5.6%) was up sharply, extending its post-election rally on news from Bloomberg that the Trump administration may ease regulations on self-driving cars. The stock has surged 37.8% since November 5, helping lift the S&P 500 consumer discretionary sector by 0.9%.

The energy sector (+1.0%) was the best performer, driven by rising commodity prices. WTI crude oil futures settled 3.2% higher at $69.18/bbl, while natural gas futures settled 5.3% higher at $2.97 per mmbtu.

Nine out of the 11 sectors closed higher than Friday’s close, indicating broad-based buying interest. The health care sector settled little changed from Friday, weighed down by Eli Lilly (LLY 727.20, -19.00, -2.6%) after reports that some Republican Senators are reportedly open to Robert F. Kennedy Jr.'s nomination for Secretary of Health and Human Services.

Today's economic data included the November NAHB Housing Market Index, which rose to 46 in November (Briefing.com consensus 43) from 43 in October. 

Looking ahead to Tuesday, the October Housing Starts and Building Permits report will be released at 8:30 ET. 

• Nasdaq Composite: +25.2%
• S&P 500: +23.6%
• S&P Midcap 400: +15.5%
• Dow Jones Industrial Average: +15.1%
• Russell 2000: +13.8%

Overseas:

• Europe: DAX -0.2%, FTSE +0.6%, CAC +0.1%
• Asia: Nikkei -1.1%, Hang Seng +0.8% Shanghai -0.2%

Commodities:

• Crude Oil +2.16 @ 69.18
• Nat Gas +0.15 @ 2.97
• Gold +43.20 @ 2613.20
• Silver +0.69 @ 31.13
• Copper +0.05 @ 4.12

After-Hours Spotlight:

• Super Micro Computer (SMCI) engages BDO USA, P.C. as its independent auditor, effective immediately... SMCI up 17.5%
• Symbotic (SYM) reports EPS in-line, beats on revs; guides Q1 revs in-line... SYM up 28.4%
• Trip.com Group (TCOM) reports Q3 results, revenue up 16% yr/yr... TCOM up 3.9%

For a full rundown of today's market and after hours developments, see Live In Play

• Earnings/Guidance (Full Earnings Calendar):
  • Bitdeer Technologies (BTDR) reports Q3 results, misses on revs
  • Brady (BRC) beats by $0.02, beats on revs; reaffirms FY25 EPS guidance
  • Corporación América Airports (CAAP) reports a 4.0% yr/yr decrease in passenger traffic in October 2024; Excluding Natal for comparison purposes, total traffic in October decreased by 1.6% YoY
  • Niu Technologies (NIU) reports Q3 results
  • Twist Bioscience (TWST) reports Q4 results, beats on revs; guides Q1 revs above consensus; guides FY25 revs in-line
• General News
  • President-elect Trump's key advisor Elon Musk is pushing Howard Lutnick for Treasury Secretary, according to Politico
  • Scott Bessent, Kevin Warsh, and Apollo (APO) CEO Marc Rowan also being considered for Treasury secretary, according to Financial Times
  • Boston Fed President Susan Collins says inflation is on a strong trajectory back to 2%, according to Bloomberg
  • President Biden authorized Ukraine to strike inside Russia with long range missiles provided by US, according to the New York Times
  • House Speaker Mike Johnson says tax cuts must be paid for, according to Bloomberg
  • Incoming Department of Government Efficiency member Vivek Ramaswamy suggests cuts in funding for federal contractors, according to Fox News interview
  • President-elect Trump wants to ease regulations on self-driving cars, according to Bloomberg
  • President-elect Trump wants assurance from incoming Treasury Secretary that he will impose sweeping tariffs, according to Financial Times
  • President-elect Trump nominates Brendan Carr to serve as FCC Commissioner
  • Preside-elect Trump nominates Chris Wright for Secretary of Energy and will be member of National Energy Council
  • Republicans Senators appear open to RFK Jr's nomination to HHS, according to The Hill
  • Most Republicans doubt that Matt Gaetz will be confirmed as Attorney General, according to NBC News
  • G-20 will support climate goals, according to Bloomberg
  • AA says nearly 80 million Americans expected to travel over Thanksgiving: 71.7 million by car; 5.84 million by air and 2.3 million by other methods
  • White House issues readout of President Joe Biden’s meeting with President Xi Jinping of the People’s Republic of China
  • Trump advisers and GOP lawmakers eye cuts to Medicaid, food stamps to fund tax cuts extension, according to WaPo
  • Some of President-elect Trump's key advisors are signaling support for Kevin Warsh for Treasury Secretary, according to Bloomberg
  • AbbVie (ABBV) receives European Commission approval of ELAHERE
  • Adverum Biotech (ADVM) announces topline 52-week results from the LUNA Phase 2 trial, new 4-year OPTIC long-term follow-up data and key pivotal program design elements
  • Air Products (APD) Announces Two New Independent Director Candidates as Part of Ongoing Board Refreshment
  • Aldeyra Therapeutics (ALDX) announces that the U.S. FDA has accepted for review the resubmitted New Drug Application for topical ocular reproxalap, a first-in-class investigational new drug candidate, for the treatment of the signs and symptoms of dry eye disease
  • Alibaba (BABA) aiming to raise $5 bln in bond deal, according to Reuters
  • Alliance Resource (ARLP) announces issuance of WARN Act notice at Excel Mining
  • Alnylam (ALNY) Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose
  • American Healthcare REIT (AHR) entered into an ATM Equity Offering Sales Agreement having an aggregate gross sales price of up to $500 million
  • Amgen (AMGN): Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024
  • Arrowhead (ARWR) announces new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational plozasiran; announces that it submitted a New Drug Application to the U.S. Food and Drug Administration for investigational plozasiran for the treatment of familial chylomicronemia syndrome, a severe and rare genetic disease which currently has no FDA approved treatments
  • AstraZeneca (AZN) reports Tagrisso recommended for EU approval
  • BAE Systems (BAESY) has received $202 million in U.S. Navy contracts to provide modernization and maintenance services aboard the guided missile destroyer USS Laboon and the amphibious assault ship USS Wasp
  • Bakkt (BKKT): Trump Media (DJT) in talks to acquire crypto firm Bakkt in push beyond social media, according to FT
  • Beacon Roofing Supply (BECN): QXO (QXO) aiming to bid for BECN, according to WSJ
  • BioCryst Pharma (BCRX) Launches ORLADEYO in Ireland
  • Biogen (BIIB) & Samsung Bioepis (SSNLF) receive European Commission approval for aflibercept biosimilar, OPUVIZ
  • BioMarin (BMRN) Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
  • Boston Scientific (BSX) WATCHMAN FLX Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
  • BridgeBio Pharma (BBIO) Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia
  • BridgeBio Pharma (BBIO) presented positive initial outcomes from the ATTRibute-CM open-label extension study of acoramidis in ATTR-CM at the American Heart Association Scientific Sessions
  • B. Riley Financial (RILY) and funds managed by Oaktree Capital Management announce the launch of a partnership between B. Riley and Oaktree in the Great American Group
  • Bunge (BG) authorizes the repurchase of an additional $500 mln of outstanding shares under previous share repurchase program
  • Cabaletta Bio (CABA) Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
  • CleanSpark (CLSK) provides update regarding trading halt on Nov 7
  • China Automotive (CAAS) approved a share repurchase program of up to $5 million of its outstanding common shares periodically over the next 12 months
  • Cisco (CSCO) and MGM Resorts International (MGM) announce that the companies have signed a Whole Portfolio Agreement (WPA), empowering MGM Resorts with the majority of Cisco's software portfolio
  • Coinbase Global (COIN) CEO Brian Armstrong will meet with President-elect Trump to discuss cabinet appointments, according to WSJ
  • Corbus Pharma (CRBP) Board member Anne Altmeyer Ph.D. adopted a Rule 10b5-1 plan providing for the sale of up to 2,452 shares of the Company’s common stock
  • Core Scientific (CORZ) and Port Muskogee broke ground today on Core Scientific’s newest state-of-the-art, high-performance computing data center
  • CVS Health (CVS) confirms Board appointments; Appointments follow productive engagement with Glenview Capital Management
  • Cybin (CYBN) Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
  • Cytokinetics (CYTO) Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
  • DTE Energy (DTE) announces the construction of three new electric substations as part of the company’s ongoing commitment to reducing power outage frequency by 30% while cutting outage time in half by 2029
  • Eco Wave Power Global AB (WAVE) received the final Nationwide Permit from the U.S. Army Corps of Engineers for its groundbreaking wave energy project at AltaSea’s premises at the Port of Los Angeles
  • Eli Lilly's (LLY) tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesity
  • Esperion (ESPR) highlights new exploratory data from CLEAR outcomes trial highlighting value of Nexletol in oral featured science session and multiple poster presentations at AHA Scientific Sessions 2024
  • Federal Realty (FRT) COO Jeffrey S. Berkes to leave the company, effective December 31; COO position will not be backfilled
  • fuboTV (FUBO) announced the availability of four new interactive Connected TV ad formats to further drive audience ad engagement
  • Gladstone Investments (GAIN), Gladstone Land (LAND), and Gladstone Commercial (GOOD) COO Terry Lee Brubaker to retire, effective December 2
  • Globalstar (GSAT) announces its intent to transfer its common stock listing to the Nasdaq Global Select Market in the first quarter of 2025
  • Globe Life's (GL) Board approved an authorization to repurchase up to $1.8 billion of common stock
  • Harmonic (HLIT): Romanesque Capital supports sale of Harmonic Inc. to maximize shareholder value
  • Henry Schein (HSIC): Activist investor Ananym Capital pushes to overhaul Board, cut costs, and consider sale of medical distribution biz, according to Reuters
  • Hyster-Yale (HY) authorized the repurchase of up to $50 million or 1.5 million shares
  • Intellia (NTLA) Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
  • Invitation Homes (INVH) Announces $200 Million Joint Venture
  • IonQ (IONQ) announces the completion of an industry-first demonstration of an end-to-end application workflow that leverages the NVIDIA CUDA-Q platform alongside IonQ’s leading quantum computing hardware
  • Johnson Controls (JCI) is continuing to grow its industry-leading national workforce development initiative, the Johnson Controls Academy
  • Larimar Therapeutics (LRMR) presented data from the Company’s Phase 1 studies and the Phase 2 dose exploration study of nomlabofusp at the International Congress for Ataxia Research in London, U.K.
  • Liberty Energy (LBRT) comments on nomination of Chris Wright as U.S. Secretary of Energy and announces succession planning for Chairman and CEO
  • Lilly's (LLY) muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose
  • Madison Square Garden Entertainment (MSGE) CFO Michael Grau to step down
  • Manulife Financial (MFC) President/CEO plans to retire in May 2025
  • Methode Electronics (MEI) entered into a Settlement Agreement with its former Director and Chief Executive Officer
  • Nektar Therapeutics (NKTR) announces its oral presentation highlighting preclinical data on NKTR-422 at the 2024 American College of Rheumatology conference
  • Netflix (NFLX) says 60 million households tuned in live for Jake Paul vs. Mike Tyson with nearly 50 million for Amanda Serrano vs. Katie Taylor
  • Netflix (NFLX) boxing match between Mike Tyson and Jake Paul had some technical problems, Bloomberg
  • Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of Rett syndrome
  • New Found Gold Corp. (NFGC) filed Queensway gold project NI 43-101 technical report
  • NewAmsterdam Pharma (NAMS) announces additional results from the Company’s Phase 3 BROOKLYN clinical trial evaluating obicetrapib in adult patients with heterozygous familial hypercholesterolemia, whose LDL-C is not adequately controlled, despite being on maximally tolerated lipid-lowering therapy
  • Novo Nordisk (NVO) prepares data on next generation of weight loss drugs, according to Financial Times
  • Nurix Therapeutics (NRIX) Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
  • nVent Electric (NVT) is collaborating with NVIDIA (NVDA) to deploy liquid cooling solutions at scale supporting the NVIDIA GB200 NVL72 and next-generation platforms
  • Nvidia (NVDA) customers worried about artificial intelligence chip overheating snag, according to The Information
  • NVIDIA (NVDA) announces omniverse real-time physics digital twins with industry software leaders
  • NVIDIA (NVDA) opens BioNeMo to scale digital biology for global biopharma and scientific industry
  • NVIDIA (NVDA) accelerates Google Quantum AI processor design with simulation of quantum device physics
  • Open Text (OTEX) expands partner ecosystem access across full OpenText Product Suite; launches new Partner Enterprise Learning Subscription
  • Patrick Industries (PATK) increases quarterly cash dividend to $0.60/share from $0.55/share; co also increases share repurchase authorization program to $200 million, including the $72.9 million remaining under the previous authorization
  • Penguin Solutions (PENG) accelerates time to value for AI factories
  • Perspective Therapeutics (CATX) to discuss data on [212Pb]VMT-a-NET presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
  • Perpetua Resources (PPTA) announces the pricing of its previously announced public offering of 3,439,465 shares of its common stock in the United States at a price to the public of $10.17
  • Petrobras (PBR) clarifies news about Business Plan 2025-2029
  • REGENXBIO (RGNX) initiates AFFINITY DUCHENNE trial of RGX-202; announced new positive efficacy and safety data from the Phase I/II portion of the study
  • Roche Hldg (RHHBY) receives CE Mark for VENTANA FOLR1 RxDx Assay
  • Rocket Pharmaceuticals (RCKT) presented long-term safety and efficacy results from the Phase 1 RP-A501 study which showed that RP-A501 was generally well tolerated and all evaluable Danon disease patients demonstrated LAMP2 protein expression at 12 months and reduction of left ventricular mass index by =10% at 12 months (sustained up to 54 months) after treatment
  • Rhythm Pharmaceuticals (RYTM) Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide
  • Samsung (SSNLF) plans to invest about KRW 20 trillion by 2030 for advanced semiconductor R&D; plans to buy back a total of KRW 10 trillion in the Company’s shares to enhance shareholder value
  • ServiceNow (NOW) to invest $2 billion in Japan to boost AI-driven services and data center expansion, according to Nikkei
  • SIGA Technologies (SIGA): CDC says California confirms first clade I mpox case
  • Silence Therapeutics (SLN) presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a short interfering RNA, in atherosclerotic cardiovascular disease patients with high lipoprotein(a) levels
  • Spirit Airlines (SAVE) enters comprehensive agreement to deleverage balance sheet; receives backstopped commitments for $350 million equity investment and $300 million in debtor-in-possession financing
  • Spirit Airlines (SAVE) Issues Open Letter to All Spirit Guests
  • Super Micro Computer (SMCI) might avoid delisting, according to Barron's
  • Super Micro Computer (SCMI) announces the highest-performing SuperCluster, an end-to-end AI data center solution featuring the NVIDIA (NVDA) Blackwell platform for the era of trillion-parameter-scale generative AI
  • Syndax Pharmaceuticals (SNDX): FDA approves revumenib, a menin inhibitor, for relapsed or refractory acute leukemia
  • Target Hospitality (TH) extends Pecos Children's Center contract; reaffirms FY24 outlook
  • Textron (TXT) secures $47 million task order from U.S. Navy to expand Aerosonde UAS support for Littoral Combat Ships
  • T-Mobile (TMUS) was among networks hacked in Chinese breach of telecom networks, according to the Wall Street Journal
  • Tutor Perini (TPC) announces that the Company, in a joint venture with O&G Industries, Inc. has been awarded a contract valued at $1.18 bln by the Port Authority of New York and New Jersey for the AirTrain Newark Replacement Program - Guideway and Stations Project at Newark Liberty International Airport in New Jersey
  • Tuya (TUYA) enters anchor investment by 65 Equity Partners
  • U.S. Gold Mining (USGO) Intersects 120 meters at 1.00 g/t Gold Equivalent - Confirms Western High-Grade Zone Within Whistler Gold-Copper Deposit, Alaska
  • U.S. Steel (X): Nippon Steel (NPSCY) making anti-import promise to gain support of workers for merger, according to Bloomberg
  • Walt Disney (DIS) has removed Star Wars from 2026 slate, according to Variety
  • Warner Brothers Discovery (WBD) settled breach of contract lawsuit against NBA, according to the Wall Street Journal
  • Whitestone REIT (WSR): MCB withdraws proposal to acquire Whitestone due to Whitestone Board's entrenchment and refusal to engage
  • Wolfspeed (WOLF) announces leadership transition; Gregg Lowe to depart as President & CEO and as a Member of the Board of Directors
  • Zimmer Biomet (ZBH) receives CE Mark Certification for Persona Revision Knee System

Ratings Changes (see Upgrades/Downgrades calendar for full list):

• Upgrades:
  • Air Products (APD) upgraded to Buy from Neutral at UBS; tgt $375
  • Amylyx Pharmaceuticals (AMLX) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $11
  • Autolus Therapeutics (AUTL) upgraded to Buy from Neutral at Goldman; tgt raised to $7.60
  • Bright Horizons (BFAM) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt lowered to $125
  • CVS Health (CVS) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $66
  • Hewlett Packard Enterprise (HPE) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $29
  • MBIA (MBI) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $9
  • Moderna (MRNA) upgraded to Buy from Hold at HSBC Securities; tgt $58
  • Monolithic Power (MPWR) upgraded to Buy from Hold at Loop Capital; tgt $660
  • Robinhood Markets (HOOD) upgraded to Buy from Hold at Needham; tgt $40
  • Roku (ROKU) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $90
  • United Fire Group (UFCS) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $26
• Downgrades:
  • Avis Budget (CAR) downgraded to Neutral from Buy at Northcoast
  • Biogen (BIIB) downgraded to Hold from Buy at Needham
  • Crane (CR) downgraded to Hold from Buy at Stifel; tgt $176
  • Curtiss-Wright (CW) downgraded to Hold from Buy at Stifel; tgt $370
  • EOG Resources (EOG) downgraded to Neutral from Overweight at Piper Sandler; tgt raised to $149
  • ESAB Corp. (ESAB) downgraded to Hold from Buy at Stifel; tgt lowered to $130
  • Eyenovia (EYEN) downgraded to Neutral from Buy at H.C. Wainwright; tgt lowered to $2
  • FB Financial (FBK) downgraded to Market Perform from Outperform at Hovde Group; tgt $60
  • Ingersoll-Rand (IR) downgraded to Hold from Buy at Stifel; tgt lowered to $107
  • Liberty Global (LBTYA) downgraded to Neutral from Buy at UBS; tgt lowered to $13
  • Matson (MATX) downgraded to Peer Perform from Outperform at Wolfe Research
  • National Bank (NBHC) downgraded to Market Perform from Outperform at Hovde Group; tgt $55
  • Parker-Hannifin (PH) downgraded to Hold from Buy at Stifel; tgt $691
  • Pinnacle Finl (PNFP) downgraded to Market Perform from Outperform at Hovde Group; tgt $135
  • Pinnacle West (PNW) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $91
  • Redfin (RDFN) downgraded to Sell from Neutral at Goldman; tgt raised to $6.50
• Others:
  • Akero Therapeutics (AKRO) initiated with a Buy at Citigroup; tgt $65
  • Astera Labs (ALAB) initiated with a Buy at Citigroup; tgt $120
  • Capricor Therapeutics (CAPR) initiated with a Buy at JonesResearch
  • enGene Holdings (ENGN) initiated with a Mkt Outperform at JMP Securities; tgt $18
  • Erasca (ERAS) initiated with a Buy at Jefferies; tgt $6
  • GATX (GATX) initiated with a Buy at Goldman; tgt $185
  • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Loop Capital; tgt $30
  • Ingram Micro Holding Corp. (INGM) initiated with an Outperform at Raymond James; tgt $28
  • Ingram Micro Holding Corp. (INGM) initiated with an Equal-Weight at Morgan Stanley; tgt $24
  • Ingram Micro Holding Corp. (INGM) initiated with a Neutral at Exane BNP Paribas; tgt $25
  • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Stifel; tgt $28
  • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Deutsche Bank; tgt $26
  • Ingram Micro Holding Corp. (INGM) initiated with a Buy at BofA Securities; tgt $30
  • Ingram Micro Holding Corp. (INGM) initiated with an Outperform at RBC Capital Mkts; tgt $26
  • Ingram Micro Holding Corp. (INGM) initiated with an In-line at Evercore ISI; tgt $27
  • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Jefferies; tgt $28
  • Ingram Micro Holding Corp. (INGM) initiated with a Buy at Redburn Atlantic; tgt $30
  • Korro Bio (KRRO) initiated with a Buy at JonesResearch
  • Penguin Solutions (PENG) initiated with a Mkt Outperform at JMP Securities; tgt $23
  • RXO, Inc. (RXO) resumed with a Neutral at Goldman; tgt $29
  • TechnipFMC (FTI) initiated with an Outperform at RBC Capital Mkts; tgt $37
  • Trinity Industries (TRN) initiated with a Neutral at Goldman; tgt $39
  • VYNE Therapeutics (VYNE) initiated with a Buy at BTIG Research; tgt $8

• Econ Data (Tuesday):
  • 8:30 ET: October Housing Starts (Briefing.com consensus 1.340 mln; prior 1.354 mln) and Building Permits (Briefing.com consensus 1.441 mln; prior 1.428 mln);
• Earnings:
  • Monday (Nov 18)
    • Pre-Market: BRC TWST
    • After-Hours: ACM BRBR SYM TCOM
  • Tuesday (Nov 19)
    • Pre-Market: AS ENR GDS J KC LOW MDT OCSL VIK VIPS VVV WMT WB
    • After-Hours: AZEK DLB GBDC KEYS LZB POWL VREX ZTO
  • Wednesday (Nov 20)
    • Pre-Market: BERY DY GLBE NIO SR TGT TJX WSM WIX
    • After-Hours: CPA JACK MMS NVDA PANW SNOW SQM
  • Thursday (Nov 21)
    • Pre-Market: ATKR BIDU BJ DE BEKE SCVL VSTS WMG
    • After-Hours: CPRT ESTC GAP INTU ROST UGI
  • Friday (Nov 22)
    • Pre-Market: BKE
    • After-Hours: None
General Motors: 5,000 members at GM's Arlington, TX assembly plant join UAW strike